Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses.

  • 11 May 1992
    • journal article
    • Vol. 3  (3) , 331-4
Abstract
We have recently described a new antitumor treatment, electrochemotherapy (ECT), based on the large local potentiation of the effects of the chemotherapeutic agent bleomycin (BLM) by electric pulses (EP) delivered at the tumor site. We demonstrate here that the host's immune response participates in cure achievement. We obtain an increase of the rate of completely cured animals by injecting mice with interleukin-2 (IL-2).

This publication has 0 references indexed in Scilit: